Sonodynamic therapy (SDT) is a promising cancer therapy due to its noninvasiveness,
negligible side effects, and deep tissue penetration. However, the effect of SDT is …

MRI contrast agents are required in the clinic to detect some pathologies, such as cancers.
Nevertheless, at the moment, only small extracellular and non-specific gadolinium …

The safety risks of gadolinium (Gd3+)-based contrast agents (GBCAs) arise from their
inevitable leakage of Gd3+, and the pursuit of more stable GBCAs for magnetic resonance …

Today, magnetic resonance imaging (MRI) is one of the most widely applied noninvasive
clinical imaging modalities with excellent applicability in bio-and nanomedicine, particularly …

Contrast-enhanced magnetic resonance imaging (CE-MRI) is a promising approach for the
diagnosis of kidney diseases. However, safety concerns, including nephrogenic systemic …

Emerging non-invasive molecular imaging modalities can detect a pathophysiological state
at the molecular level before any anatomic changes are observed. Magnetic resonance …

The leakage of gadolinium ions (Gd3+) from commercial Gd3+-based contrast agents
(GBCAs) in patients is currently the major safety concern in clinical magnetic resonance …

Effective vascular and hepatic enhancement and better safety are the key drivers for
exploring gadolinium-free hepatobiliary contrast agents. Herein, a facile strategy proposes …

Gadolinium (III)-based contrast agents (GBCAs) play a dominant role in contrast enhanced
magnetic resonance imaging (MRI) and are used to improve the accuracy of diagnoses. In …

Controversy surrounding gadolinium-based contrast agents (GBCAs) has rendered their
continued utility highly contentious, but the liver-specific GBCA Gd (III) ethoxybenzyl …